Prime Medicine Inc [PRME]
Pivot Data
Pivot Statistics
| Metric | Average | Median | Std Dev |
|---|---|---|---|
| Gain % | 31.72% | 31.35% | 8.84% |
| Loss % | -28.16% | -30.77% | 4.86% |
| Duration | 18.0d | 19d | 7.8d |
| Total Pivots Found | 12 |
| Gain/Loss Legs | 11 (6 Gain / 5 Loss) |
| Last Pivot | Top @ $3.23 on 2026-06-18 |
| Change since Last Pivot | $0.00 (0.00%) |
Next Pivot Prediction Last: $3.38
| Predicted Next Type | Bottom |
| Predicted Price (Avg) | $2.32 |
| Predicted Price (Median) | $2.24 |
| Predicted Price Range (~68%) | $2.16 - $2.48 |
| Change to Avg Target | $-1.05 (-31.25%) |
| Predicted Date (Avg) | 2026-07-06 |
| Predicted Date Range (~68%) | 2026-06-28 - 2026-07-13 |
| Basis | Based on 5 historical losses (Avg: -28.16%, Median: -30.77%, StdDev of Abs: 4.86%) and duration (Avg: 18.0 days, StdDev: 7.8 days) |
| Note | Ranges assume ~normal distribution & historical patterns repeat. Use with caution. |
Prime Medicine Inc rose moderately, up 2.22% on Thursday.
Prime Medicine Inc (PRME) stock price saw a healthy increase on Thursday after the stock rose $0.0700 (2.22%) from the previous session on normal volume. The stock slightly outperformed the market today, moving slightly ahead of the NASDAQ's 1.91% rise. With 3.50M shares traded, volume yesterday reached $11.31M. This was 709 702 shares less than the prior day. Compared to the 10-day average of 2.92M shares, volume was more than the average.
Prime Medicine Inc signals
There is no conclusive signals given from RSI. The price is below both moving averages, and the short-term average is below the long-term average, confirming a sustained down-trend. Market in Equilibrium: A state of indecision prevails across all timeframes, with signals mixed in the short- (-16.7%), medium- (-16.7%), and long-term (-16.7%) horizons. This balance between forces suggests a period of consolidation and the absence of a clear directional catalyst.
Prime Medicine Inc Support & Resistance Levels
The stock is trading above the closest support level at $2.97. approximately $0.260 (8.05%) away. This suggests it is currently acting as a floor, approaching it.The sup dis das support s12.97 -
Prime Medicine Inc Evaluation
- Short score: -1.22
- Medium score: -2.21
- Long score: -2.64